Core Laboratories NV (CLB)
Pretax margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | ||
|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | 45,434 | 36,313 | 31,439 | 34,385 |
| Revenue (ttm) | US$ in thousands | 520,526 | 517,009 | 504,808 | 498,822 |
| Pretax margin | 8.73% | 7.02% | 6.23% | 6.89% |
December 31, 2024 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $45,434K ÷ $520,526K
= 8.73%
To analyze Core Laboratories NV's pretax margin, we calculated the ratio for each quarter in 2024. The pretax margin measures the company's ability to generate profits before taxes relative to its revenue.
Core Laboratories NV's pretax margin has shown a fluctuating trend throughout the year. It started at 6.89% in March 2024, decreased to 6.23% in June, then increased to 7.02% in September, and experienced a significant improvement to reach 8.73% in December.
The improvement in pretax margin from June to December suggests that the company has been successful in managing its operating expenses and increasing its efficiency in generating profits before taxes. Overall, Core Laboratories NV exhibited a positive trend in its pretax margin over the year, which may indicate stronger financial performance and profitability.
Peer comparison
Dec 31, 2024